Form D · Biotechnology
BIOIMAGENE INC
Sunnyvale, CA · CIK 0001268042
Offering snapshot reported Oct 20, 2009 · SEC filing
- Reported sold
- $12M Offering amount: $44.7M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 14, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 20, 2009 | Initial | $12,000,000 | No comparison | 3 | SEC filing |
| Aug 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-59726
Source: Form D, filed Oct 20, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| G. Steven Burrill | Director |
| John Dean | Director, Executive |
| Matthew Hermann | Director |
| Joseph Keegan | Director |
| Yatin Mundkur | Director |
| Vivek Pathak | Executive |
| Ajit Singh | Director, Executive |
| Mohan Uttarwar | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
919 Hermosa Court
Sunnyvale, CA, 94085
Sunnyvale, CA, 94085